Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seraina Faes

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Frontiers in Surgery|October 29, 2021
Elective Surgery for Diverticulitis in Swiss HospitalsSeraina Faes, Martin Hübner, Nicolas Demartines, et al.
Biochemical and Biophysical Research Communications|August 17, 2014
PGE2-induced colon cancer growth is mediated by mTORC1Marc Dufour, Seraina Faes, Anne Dormond-Meuwly, et al.
Biochemical and Biophysical Research Communications|April 15, 2019
Rebound pathway overactivation by cancer cells following discontinuation of PI3K or mTOR inhibition promotes cancer cell growthSeraina Faes, Tania Santoro, Laetitia Troquier, et al.
Revue Medicale Suisse|June 14, 2023
[Anal cancer screening. A decade's experience of a consultation in a tertiary centre]Iolanda Espirito Santo, Céline Duvoisin Cordoba, Martin Hübner, et al.
Oncotarget|November 17, 2016
Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapiesSeraina Faes, Emilie Uldry, Anne Planche, et al.
Cancers|January 25, 2025
Anal Cancer Screening: 10-Year Experience of a Specialized Outpatient ClinicIolanda Espirito Santo, Amaniel Kefleyesus, Camille Chilou, et al.
Cancers|October 26, 2024
Concomitant Cervical and Anal Screening for Human Papilloma Virus (HPV): Worth the Effort or a Waste of Time?Camille Chilou, Iolanda Espirito Santo, Seraina Faes, et al.
Annals of Surgery|July 12, 2023
Ondansetron for Low Anterior Resection Syndrome (LARS): A Double-Blind, Placebo-Controlled, Cross-Over, Randomized StudySotirios Georgios Popeskou, Raffaello Roesel, Seraina Faes, et al.
Oncotarget|May 7, 2016
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitorsSeraina Faes, Anne Planche, Emilie Uldry, et al.
Molecular Cancer|December 7, 2016
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitorsSeraina Faes, Adrian P Duval, Anne Planche, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Surgery|October 29, 2021
Elective Surgery for Diverticulitis in Swiss HospitalsSeraina Faes, Martin Hübner, Nicolas Demartines, et al.
Biochemical and Biophysical Research Communications|August 17, 2014
PGE2-induced colon cancer growth is mediated by mTORC1Marc Dufour, Seraina Faes, Anne Dormond-Meuwly, et al.
Biochemical and Biophysical Research Communications|April 15, 2019
Rebound pathway overactivation by cancer cells following discontinuation of PI3K or mTOR inhibition promotes cancer cell growthSeraina Faes, Tania Santoro, Laetitia Troquier, et al.
Revue Medicale Suisse|June 14, 2023
[Anal cancer screening. A decade's experience of a consultation in a tertiary centre]Iolanda Espirito Santo, Céline Duvoisin Cordoba, Martin Hübner, et al.
Oncotarget|November 17, 2016
Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapiesSeraina Faes, Emilie Uldry, Anne Planche, et al.
Cancers|January 25, 2025
Anal Cancer Screening: 10-Year Experience of a Specialized Outpatient ClinicIolanda Espirito Santo, Amaniel Kefleyesus, Camille Chilou, et al.
Cancers|October 26, 2024
Concomitant Cervical and Anal Screening for Human Papilloma Virus (HPV): Worth the Effort or a Waste of Time?Camille Chilou, Iolanda Espirito Santo, Seraina Faes, et al.
Annals of Surgery|July 12, 2023
Ondansetron for Low Anterior Resection Syndrome (LARS): A Double-Blind, Placebo-Controlled, Cross-Over, Randomized StudySotirios Georgios Popeskou, Raffaello Roesel, Seraina Faes, et al.
Oncotarget|May 7, 2016
Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitorsSeraina Faes, Anne Planche, Emilie Uldry, et al.
Molecular Cancer|December 7, 2016
Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitorsSeraina Faes, Adrian P Duval, Anne Planche, et al.
Pageof 3